VINC logo

Vincerx Pharma (VINC) Company Overview

Profile

Full Name:

Vincerx Pharma, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

May 27, 2020

Indexes:

Not included

Description:

Vincerx Pharma is a biotechnology company focused on developing innovative therapies for cancer treatment. They create targeted medicines that aim to improve patient outcomes by addressing specific cancer types. Their research combines advanced technology and scientific expertise to advance cancer care.

Events Calendar

Earnings

Next earnings date:

Mar 28, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Mar 29, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jan 28, 2025

Analyst ratings

Recent major analysts updates

Oct 8, 24 Leerink Partners
Outperform
Apr 9, 24 Cantor Fitzgerald
Overweight
Apr 1, 24 Cantor Fitzgerald
Overweight
Sep 7, 23 Cantor Fitzgerald
Overweight
Nov 17, 22 Chardan Capital
Buy
Aug 12, 22 SVB Leerink
Outperform
Jun 8, 22 Cantor Fitzgerald
Overweight
Jun 7, 22 SVB Leerink
Outperform
Jun 7, 22 Chardan Capital
Buy
Jun 7, 22 B. Riley Securities
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Vincerx Pharma?
  • Does Vincerx Pharma pay dividends?
  • What sector is Vincerx Pharma in?
  • What industry is Vincerx Pharma in?
  • What country is Vincerx Pharma based in?
  • When did Vincerx Pharma go public?
  • Is Vincerx Pharma in the S&P 500?
  • Is Vincerx Pharma in the NASDAQ 100?
  • Is Vincerx Pharma in the Dow Jones?
  • When was Vincerx Pharma's last earnings report?
  • When does Vincerx Pharma report earnings?
  • Should I buy Vincerx Pharma stock now?

What is the ticker symbol for Vincerx Pharma?

The ticker symbol for Vincerx Pharma is NASDAQ:VINC

Does Vincerx Pharma pay dividends?

No, Vincerx Pharma does not pay dividends

What sector is Vincerx Pharma in?

Vincerx Pharma is in the Healthcare sector

What industry is Vincerx Pharma in?

Vincerx Pharma is in the Biotechnology industry

What country is Vincerx Pharma based in?

Vincerx Pharma is headquartered in United States

When did Vincerx Pharma go public?

Vincerx Pharma's initial public offering (IPO) was on May 27, 2020

Is Vincerx Pharma in the S&P 500?

No, Vincerx Pharma is not included in the S&P 500 index

Is Vincerx Pharma in the NASDAQ 100?

No, Vincerx Pharma is not included in the NASDAQ 100 index

Is Vincerx Pharma in the Dow Jones?

No, Vincerx Pharma is not included in the Dow Jones index

When was Vincerx Pharma's last earnings report?

Vincerx Pharma's most recent earnings report was on Nov 12, 2024

When does Vincerx Pharma report earnings?

The next expected earnings date for Vincerx Pharma is Mar 28, 2025

Should I buy Vincerx Pharma stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions